Please Wait

Applying Filters...

Drug Product Composition: Ceftazidime Sodium

Ceftazidime Sodium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 18 USDMF, 16 CEP/COS, 6 JDMF, 4 EU WC, 4 KDMF, 4 NDC API, 14 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

6 Intermediates Suppliers

6 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

221 FDF Dossiers, 42 FDA Orange Book, 100 Europe, 6 Canada, 16 South Africa, 57 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 0.5GM BASE;2GM/VIAL, INJECTABLE;INJECTION - 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 6GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 20MG BASE/ML, INJECTABLE;INJECTION - EQ 40MG BASE/ML, INJECTABLE;INJECTION - EQ 1GM BASE, INJECTABLE;INJECTION - EQ 2GM BASE

RELATED EXCIPIENT COMPANIES

1 Actylis, 1 Kerry, 1 Microlex e.U, 1 Pluviaendo, 1 Roquette

EXCIPIENTS BY APPLICATIONS

2 Parenteral, 2 Fillers, Diluents & Binders, 1 Co-Processed Excipients, 1 Taste Masking

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 25 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 82 Finished Drug Prices, 8 Annual Reports

MARKET PLACE

20 APIs, 20 FDF Dossiers

PATENTS & EXCLUSIVITIES

10 US Patents, 4 US Exclusivities, 16 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 4 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 206494 / DOSAGE - POWDER;INTRAVENOUS - EQ 0.5GM BASE;2GM/VIAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
AVIBACTAM SODIUM(UNII: 9V824P8TAI) (AVIBACTAM - UNII:7352665165)	AVIBACTAM	0.5g
CEFTAZIDIME(UNII: 9M416Z9QNR) (CEFTAZIDIME ANHYDROUS - UNII:DZR1ENT301)	CEFTAZIDIME ANHYDROUS	2g

Inactive Ingredients

Ingredient Name	Allergan, Inc.
SODIUM CARBONATE(45P3261C7T)

Drug Product Composition: Ceftazidime Sodium

Ceftazidime Sodium

Ceftazidime Sodium

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

39 API Suppliers

18 USDMF

16 CEP/COS

6 JDMF

4 EU WC

4 KDMF

4 NDC API

14 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

INTERMEDIATES

6 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

221 FDF Dossiers

42 FDA Orange Book

100 Europe

6 Canada

16 South Africa

57 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 0.5GM BASE;2GM/VIAL

INJECTABLE;INJECTION - 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 6GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 20MG BASE/ML

INJECTABLE;INJECTION - EQ 40MG BASE/ML

INJECTABLE;INJECTION - EQ 1GM BASE

INJECTABLE;INJECTION - EQ 2GM BASE

RELATED EXCIPIENT COMPANIES

1 Actylis

1 Kerry

1 Microlex e.U

1 Pluviaendo

1 Roquette

EXCIPIENTS BY APPLICATIONS

2 Parenteral

2 Fillers, Diluents & Binders

1 Co-Processed Excipients

1 Taste Masking

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow

25 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions

82 Finished Drug Prices

8 Annual Reports

MARKET PLACE

20 APIs

20 FDF Dossiers

PATENTS & EXCLUSIVITIES

10 US Patents

4 US Exclusivities

16 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM

2 USP

4 Others

Filters

INJECTABLE;INJECTION - 1GM/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 2GM/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 500MG/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 6GM/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons